Positron emission tomography/MRI for cardiac diseases assessment.

Related Articles

Positron emission tomography/MRI for cardiac diseases assessment.

Br J Radiol. 2020 Sep 01;93(1113):20190836

Authors: Manabe O, Oyama-Manabe N, Tamaki N

Functional imaging tools have emerged in the last few decades and are increasingly used to assess the function of the human heart in vivo. Positron emission tomography (PET) is used to evaluate myocardial metabolism and blood flow. Magnetic resonance imaging (MRI) is an essential tool for morphological and functional evaluation of the heart. In cardiology, PET is successfully combined with CT for hybrid cardiac imaging. The effective integration of two imaging modalities allows simultaneous data acquisition combining functional, structural and molecular imaging. After PET/CT has been successfully accepted for clinical practices, hybrid PET/MRI is launched. This review elaborates the current evidence of PET/MRI in cardiovascular imaging and its expected clinical applications for a comprehensive assessment of cardiovascular diseases while highlighting the advantages and limitations of this hybrid imaging approach.

PMID: 32023123 [PubMed - indexed for MEDLINE]

Source link

Related posts

Even minor sleep problems raise women’s blood pressure


Heartbeat: The ongoing controversy of intervention for chronic total coronary occlusions


The TMVr Operator Volume and Outcome Relationship: More Is More


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy